Stock report · Delisted · Nasdaq
2Seventy Bio Inc (TSVT)
5.00USD Delisted Final close · May 12, 2025
TSVT no longer trades. 2Seventy Bio was delisted from the Nasdaq in May 2025.
All prices on this page are historical. The last trade was on May 12, 2025, at $5.00.
TSVT stock price history
Final trading statistics
- Final close
- $5.00
- Final trading day
- May 12, 2025
- Market cap at delisting
- $266.14M
- Shares outstanding
- 53.23M
- Final 52-week range
- $2.29 – $5.30
- Avg. volume (final 3 mo.)
- 1,364,624
- All-time high
- $42.56 · Nov 2021
- All-time low
- $1.57 · Nov 2023
- Return since IPO
- -63.7%
- Beta
- 1.05
- Book value / share
- $4.08
- Price / book
- 1.23
About 2Seventy Bio Inc
2seventy bio was a U.S. cell and gene therapy company that researched, developed and sold cancer treatments. Its pipeline included Abecma, a CAR T-cell product for multiple myeloma, and it had a collaboration with Bristol Myers Squibb.
The company was incorporated in 2021 and based in Cambridge, Massachusetts. Its stock was delisted from the Nasdaq in May 2025, with the last trade on May 12, 2025 at $5.00.
- Exchange (former)
- Nasdaq
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Cambridge, MA
- Employees
- 65
- IPO date
- November 3, 2021
- Delisted
- May 12, 2025
- SEC CIK
- 1860782
2Seventy Bio financials before the delisting
The last 5 fiscal years 2Seventy Bio reported as a public company, fiscal year ending December.
TSVT revenue and net income
TSVT earnings per share
TSVT annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $37.86M | −$57.2M | −$1.06 |
| FY2023 | $100.39M | −$217.6M | −$4.02 |
| FY2022 | $91.50M | −$254.1M | −$7.58 |
| FY2021 | $54.52M | −$292.2M | −$12.77 |
| FY2020 | $248.12M | −$138.2M | −$3.68 |
Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.
2Seventy Bio stock FAQ
What happened to 2Seventy Bio stock?
2Seventy Bio was delisted from the Nasdaq in May 2025. The final close was $5.00 on May 12, 2025.
Can I still buy TSVT stock?
No. TSVT is no longer listed on the Nasdaq or any other U.S. exchange; it was removed on May 12, 2025.
What was the last price of TSVT?
TSVT last closed at $5.00 on May 12, 2025, which valued the company at about $266.14M.
How did 2Seventy Bio do in its last full fiscal year?
In fiscal 2024, its last full year as a public company, 2Seventy Bio reported revenue of $37.86M and net income of −$57.2M.
When did 2Seventy Bio go public?
2Seventy Bio shares started trading on November 3, 2021.
TSVT no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.